Zurich, Switzerland
PIPRA, a promising startup in the Health Care and Medical Devices sectors, is addressing a critical gap in surgical care with its innovative AI-driven tool. Established in 2019 and headquartered in Switzerland, the company focuses on reducing the incidence of post-surgical cognitive disorders through effective risk assessment and prevention.
The company’s primary solution targets a significant concern: over 25% of patients over the age of 60 experience cognitive impairment from surgical complications such as Post-Operative Delirium (POD) and Post-Operative Cognitive Decline/Dysfunction (POCD). These conditions lead to lengthier hospital stays, increased healthcare costs, and severe cognitive decline, especially in cases lacking preventive interventions.
With no existing treatments for POD and POCD, PIPRA’s tool is poised to enhance surgical outcomes and patient quality of life. Recently, the startup secured a $250.00K Seed Round from Newchip Accelerator on 23 January 2023, underlining its potential for impactful growth in the healthcare sector.
